Advertisement

Topics

Latest "Threshold Pharmaceuticals Reports Second Quarter Financial Results" News Stories

20:34 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Threshold Pharmaceuticals Reports Second Quarter Financial Results" found in our extensive news archives from over 250 global news sources.

More Information about Threshold Pharmaceuticals Reports Second Quarter Financial Results on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Threshold Pharmaceuticals Reports Second Quarter Financial Results for you to read. Along with our medical data and news we also list Threshold Pharmaceuticals Reports Second Quarter Financial Results Clinical Trials, which are updated daily. BioPortfolio also has a large database of Threshold Pharmaceuticals Reports Second Quarter Financial Results Companies for you to search.

Showing "Threshold Pharmaceuticals Reports Second Quarter Financial Results" News Articles 1–25 of 29,000+

Monday 18th March 2019

Bioceres Crop Solutions Corp. Reports Financial Results for the Second Quarter and First Half Ended December 31, 2018

Following the consummation on March 14, 2019 of the previously announced business combination between Bioceres LLC and Union Acquisition Corp., Bioceres Crop Solutions Corp. (“Bioceres Crop Solutions”, the “Company”, “we”, “us” or “our”) (NYSE American: BIOX), a fully integrated provider of crop productivity solutions company, today announced ...


FANCL Regains Control of Their IT Roadmap by Switching to Rimini Street Support for its SAP Application

Leading manufacturer of additive-free cosmetics and health food products in Japan accelerates digital transformation and obtains premium-level support Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesfo...

DJO® Announces Presentation of Independent Clinical Study Using CMF™ Device

Spine Summit 2019 Presentation by Oregon Health & Science University Shows Patients Receiving Proprietary Combined Magnetic Field (CMF™) Treatment Experienced Significantly Improved Results DJO®, a leading global provider of medical technologies designed to get and keep people moving, announced today Oregon Health & Science University’s in...


A fertility tracking app, Dot, is billing itself as contraception — and touting the results of a new efficacy study. But there’s also significant debate over how to measure the effectiveness of these tools. https://buff.ly/2CpdQpO 

A fertility tracking app, Dot, is billing itself as contraception — and touting the results of a new efficacy study. But there’s also significant debate over how to measure the effectiveness of these tools. https://buff.ly/2CpdQpO 

Telix Pharmaceuticals Limited (TLX-AU): Updated PCa imaging guidelines de-risk lead asset

goetzpartners securities Limited 18-March-2019 / 20:05 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail cli...

Aptar Pharma’s Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression

Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. This marks the first FDA approval and U.S. launch of a prescription drug using Aptar Pharma’s patented Bidose nasal spray delivery system. This press ...

A fertility app bills itself as contraception, raising questions about marketing and efficacy

A fertility tracking app, Dot, is billing itself as contraception — and touting the results of a new efficacy study. But there’s also significant debate over how to measure the…

Polymeric Polyol Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Polymeric Polyol report provides an independent information about the Polymeric Polyol industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The rep...

Halo Labs Continues to Expand Nevada Business

Halo Products Now Available in 21 of the State's 64 Dispensaries Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTC: AGEEF, Germany: A9KN) is pleased to provide a progress update on its Nevada business. The Company launched its first product offering in Nevada in the fall of 2018. Halo has primarily focused its activi...

Pure Biodiesel Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Pure Biodiesel report provides an independent information about the Pure Biodiesel industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The report ...

Cerecor Inc.: Cerecor Reports Fourth Quarter and Full Year 2018 Results

-Significant Advancement in Pipeline and Regulatory Milestones -Meets Increased 2018 Revenue Guidance -Announces Net Revenue Guidance of $20-22 Million for 2019 ROCKVILLE, MD / ACCESSWIRE / March 1...

Champions Oncology, Inc.: Champions Oncology Reports Quarterly Revenue of $6.4 Million

Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019 HACKENSACK, NJ / ACCESSWIRE / March 18, 2019 / Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end rang...

Tilray, Inc. Reports Full Year 2018 Financial Results

Revenue Rises 110.0% to $43.1 (C$56.4) Million in 2018Strategic Partnerships and Acquisitions Position Tilray to Accelerate Global Sales Growth and Drive Long-Term Shareholder Value Tilray, Inc., (“Tilray” or the “Company”) (Nasdaq: TLRY) a global leader in cannabis research, cultivation, production and distribution, today report...

Urovant Sciences to Announce Topline Results from the EMPOWUR Phase 3 Study of Vibegron in Patients with Overactive Bladder

Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced it will host a conference call and live webcast to discuss topline results from the EMPOWUR international pivotal phase 3 study on Tuesday, March 19, 2019 at 8:30 a.m. ET. A ques...

Akebia Therapeutics Announces Preliminary Full-Year 2018 Financial Results and Business Highlights

– Substantial revenue growth opportunity for Auryxia following robust 2018 commercial performance – – First regulatory submission for vadadustat expected in 2019 in Japan, following positive top-line results from pivotal phase 3 studies in Japanese subjects with anemia due to chronic kidney disease – – Multiple vadadustat phase ...

GW sells priority review voucher for $105m

GW Pharmaceuticals is selling its rare paediatric disease priority review voucher (PRV) for $105 million to Biohaven Pharmaceutical.

Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for HER2 (ERBB2) Mutant, Metastatic Cervical Cancer at the Society of Gynecologic Oncology (SGO) 2019 Annual Meeting

Oral Plenary Presentation Receives SGO Presidential Award Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced today that updated results from the cervical cancer cohort of SUMMIT, an ongoing Phase II basket trial examining the efficacy of neratinib in HER2-mutated cancers, were reported at the Society of Gynecologic Oncology...

Research in Nature reports a site-selective, versatile aromatic C-H functionalization reaction involving a thioanthrenium synthetic lynchpin. https://go.nature.com/2Fj2Egi pic.twitter.com/tviTCIoODd

Research in Nature reports a site-selective, versatile aromatic C-H functionalization reaction involving a thioanthrenium synthetic lynchpin. https://go.nature.com/2Fj2Egi  pic.twitter.com/tviTCIoODd

Champions Oncology, Inc (CSBR) CEO Ronnie Morris on Q3 2019 Results - Earnings Call Transcript

Latest Research Continues to Validate the Etiometry Platform’s Impact on Critical Care

The American College of Cardiology Conference unveiled a first-of-its kind study evaluating the effect of a digital health platform based on registry data. The abstract presented by Dr. Mary K. Olive, Pediatric Cardiac Critical Care Physician at C.S. Mott Children’s Hospital, is now a part of the growing evidence associating Etiometry’s...

Humans Can Sense Earth's Magnetic Field, Brain Imaging Study Says

Do human beings have a magnetic sense? Biologists know other animals do. They think it helps creatures including bees, turtles and birds navigate through the world. Scientists have tried to investigate whether humans belong on the list of magnetically sensitive organisms. For decades, there’s been a back-and-forth between positive reports and failures to demonstrate the trait in people, with se...

Dr. Jonathan Zaidan of Women's Excellence Promotes Excision of Endometriosis for Endometriosis Awareness Month

Dr. Jonathan Zaidan is the #1 robotic surgeon for excision of endometriosis in the Midwest. DETROIT (PRWEB) March 18, 2019 Dr. Jonathan Zaidan, MD, FACOG, President of Women’s Excellence discusses excision of endometriosis in recent blog post at https://www.womensexcellence.com/blog/excision-endometriosis-treatment-2/. In addition, Dr. Zaidan has published pathology reports to educate women o...

Polypropylene Staple Fibre Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Polypropylene Staple Fibre report provides an independent information about the Polypropylene Staple Fibre industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent...

The Philadelphia Adult Congenital Heart Center Earns Accreditation from the Adult Congenital Heart Association (ACHA)

Joint program between Children’s Hospital of Philadelphia and Penn Medicine is the first Delaware Valley institution to have earned ACHA Adult Congenital Heart Disease (ACHD) Accreditation MEDIA, Pa. (PRWEB) March 18, 2019 In recognition of its expertise in serving adults with congenital heart disease (CHD), the Philadelphia Adult Congenital Heart Center has received accreditation from the Adul...

Daiichi Sankyo show positive results for atrial fibrillation treatment Lixiana (edoxoban) http://bit.ly/2Y7Hn0f  @EUdaiichisankyo #pharmapic.twitter.com/rO5PBNNyUt

Daiichi Sankyo show positive results for atrial fibrillation treatment Lixiana (edoxoban) http://bit.ly/2Y7Hn0f  @EUdaiichisankyo #pharma pic.twitter.com/rO5PBNNyUt


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks